Population pharmacokinetics of ciprofloxacin in pediatric patients.
about
Recommended reading in population pharmacokinetic pharmacodynamicsData Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo).Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyDosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulationPopulation pharmacokinetic-pharmacodynamic analysis for sugammadex-mediated reversal of rocuronium-induced neuromuscular blockade.Erectile dysfunction secondary to nerve-sparing radical retropubic prostatectomy: comparative phosphodiesterase-5 inhibitor efficacy for therapy and novel prevention strategies.Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearancePopulation pharmacokinetic studies in pediatrics: issues in design and analysis.Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.Prophylactic ranitidine treatment in critically ill children--a population pharmacokinetic study.Cross-validation for nonlinear mixed effects modelsThe allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults.Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones.Safety Concerns Surrounding Quinolone Use in Children.Clonidine clearance matures rapidly during the early postnatal period: a population pharmacokinetic analysis in newborns with neonatal abstinence syndrome.Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.Pathogen incidence and antibiotic resistance patterns of catheter-associated urinary tract infection in children.Population pharmacokinetics of infliximab in patients with ankylosing spondylitis.
P2860
Q24647906-0A1B7E28-B14A-4937-A301-27F19A84707DQ31147438-4BE07EDF-488A-4A50-BF3A-8077604142D2Q33827819-89E63FED-8CE8-4013-8C07-1F9ABAA2F8FFQ35210471-0F8F2CBE-DD52-4904-B62C-240797FEEA60Q35219646-EDCE2DA7-AFBA-40B1-A2C3-596EA39CAF7FQ35947449-A4429015-BBCC-4405-BF95-AAC619E2CFE6Q36024899-09DC02EE-41F4-4099-8B10-65FD3C9EA1A1Q36341632-0B016A94-4C0B-415B-80C3-7587468BE95DQ36536474-B1836F9E-DBC9-479A-8719-E0C749C695DBQ36747438-EDA1A7E2-307B-4A9B-BB97-671354F37480Q36792973-125D60E5-821D-40A5-9FB0-6AD65C0EA70BQ36891147-9B181408-4299-449D-98AF-BCA93DB2CAE4Q37492046-16DB8FDE-5B14-4C73-B24D-E0B3D6357493Q38040734-F7A7ECC3-197A-4923-B099-CC0C932481F9Q38728987-031AEB67-7073-4A7D-AC2B-F9C7FD7D0005Q42661142-3462437A-8DDD-4F10-8F69-785890FB8322Q42684527-1BA0B088-040A-4F15-B27D-165844A40F08Q43195352-0A1BFAC7-5D21-4F8F-855F-8FCF87DC4BFAQ46653850-57AF6A8D-8523-42C7-994A-3EE9B112F8D9
P2860
Population pharmacokinetics of ciprofloxacin in pediatric patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Population pharmacokinetics of ciprofloxacin in pediatric patients.
@en
Population pharmacokinetics of ciprofloxacin in pediatric patients.
@nl
type
label
Population pharmacokinetics of ciprofloxacin in pediatric patients.
@en
Population pharmacokinetics of ciprofloxacin in pediatric patients.
@nl
prefLabel
Population pharmacokinetics of ciprofloxacin in pediatric patients.
@en
Population pharmacokinetics of ciprofloxacin in pediatric patients.
@nl
P2860
P356
P1476
Population pharmacokinetics of ciprofloxacin in pediatric patients.
@en
P2093
Marc R Gastonguay
Prabhu Rajagopalan
P2860
P304
P356
10.1177/0091270003254802
P577
2003-07-01T00:00:00Z